Switch to:
More From Other Websites
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis Oct 20 2014
Two Tribes Go to War: Amgen Sues Regeneron for Patent Infringement Oct 17 2014
Regeneron Eye Drug Beats Rivals While Amgen Sues Oct 17 2014
[video] Positive for Regeneron: Cramer Oct 17 2014
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex... Oct 16 2014
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex... Oct 16 2014
New Survey Finds Differences In Attitudes About Diabetes Based On Age Oct 15 2014
A Drug Regrew A Little Girl's Missing Bones. How Much Should That Cost? Oct 14 2014
Weyerhaeuser, Elizabeth Arden, Eni, SAP and Sanofi highlighted as Zacks Bull and Bear of the Day Oct 14 2014
Alnylam Drug Scores Against Rare Nerve Disease Oct 13 2014
Eurozone May Enter Triple-Dip Recession: 3 Stocks to Dump Oct 13 2014
Fed to the rescue…again! Oct 08 2014
Illumina Pads Gene Sequencing Lead With Pharma Deals Oct 08 2014
Why Unilife (UNIS) Stock Continues to Surge Today Oct 08 2014
Amgen's Data on Evolocumab Published in The Lancet Oct 08 2014
Market News: Advanced Technologies, Durata Therapeutics, Unilife Oct 06 2014
Why Unilife (UNIS) Stock Is Up Today Oct 06 2014
MannKind Receives $150 Million Upfront Payment from Sanofi Oct 03 2014
Regeneron-Sanofi's Dupilumab Meets All Endpoints Oct 03 2014
Eurozone Exports Gear Up For Currency Advantage Oct 02 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK